Clinical signs and symptoms of mucocutaneous lymph node syndrome (Kawasaki disease)
- PMID: 529600
Clinical signs and symptoms of mucocutaneous lymph node syndrome (Kawasaki disease)
Similar articles
-
[Kawasaki disease - mucocutaneous lymph node syndrome (author's transl)].Lijec Vjesn. 1981 Jul;103(7):297-300. Lijec Vjesn. 1981. PMID: 7334911 Croatian. No abstract available.
-
[Mucocutaneous lymph node syndrome, Kawasaki disease].Ned Tijdschr Geneeskd. 1978 Aug 12;122(32):1184-7. Ned Tijdschr Geneeskd. 1978. PMID: 673055 Dutch. No abstract available.
-
Kawasaki disease in Ireland.Ir Med J. 1981 Mar;74(3):85-6. Ir Med J. 1981. PMID: 7203983 No abstract available.
-
Kawasaki disease in the United States.J Infect Dis. 1978 Jan;137(1):91-3. J Infect Dis. 1978. PMID: 342638 Review. No abstract available.
-
[Progress in the studies on Kawasaki disease].Nihon Rinsho. 1983;41(1):180-90. Nihon Rinsho. 1983. PMID: 6341656 Review. Japanese. No abstract available.
Cited by
-
Kawasaki disease patients homozygous for the rs12252-C variant of interferon-induced transmembrane protein-3 are significantly more likely to develop coronary artery lesions.Mol Genet Genomic Med. 2014 Jul;2(4):356-61. doi: 10.1002/mgg3.79. Epub 2014 May 14. Mol Genet Genomic Med. 2014. PMID: 25077179 Free PMC article. No abstract available.
-
Outbreak of Kawasaki syndrome.Acta Paediatr Scand. 1987 Mar;76(2):356-7. doi: 10.1111/j.1651-2227.1987.tb10474.x. Acta Paediatr Scand. 1987. PMID: 3591304 Free PMC article. No abstract available.
-
MicroRNA-93 may control vascular endothelial growth factor A in circulating peripheral blood mononuclear cells in acute Kawasaki disease.Pediatr Res. 2016 Sep;80(3):425-32. doi: 10.1038/pr.2016.93. Epub 2016 Apr 18. Pediatr Res. 2016. PMID: 27089500
-
Neutrophil extracellular trap from Kawasaki disease alter the biologic responses of PBMC.Biosci Rep. 2020 Sep 30;40(9):BSR20200928. doi: 10.1042/BSR20200928. Biosci Rep. 2020. PMID: 32808647 Free PMC article.